It's not a claim. Remember this board is also open to opinion and to share opinions on how the situation may or may not play out. Hence I said I think they should find sufficient amount of sick patients to dose. One would argue, you using current COVID 19 numbers in South Korea is also not sufficient evidence to suggest otherwise either.
Yeah, I'm concerned about the numbers in South Korea - they are only reporting 55 patients in serious condition. Obviously good that fewer people are sick, but may be bad from the standpoint of trial enrolment...
Market Data 
Markets 
AI
